The Food and Drug Administration on Friday approved a new gene-editing therapy to treat sickle cell disease, a debilitating blood disorder that affects at least 100,000 Americans, most of whom are ...

The shape of sickle cell blood cells resembles a curved blade knife called a sickle. These cells are stiff and inflexible, so they cannot move through small blood vessels as easily as healthy red ...

Victoria Gray was wandering through the British Museum in London last week when she spotted a small wooden cross hanging on the wall. "It's nice seeing all the old artifacts, especially the cross," ...

Sickle cell anemia is an inherited condition that follows an autosomal recessive inheritance pattern. Even if you don’t have sickle cell anemia, you could be a carrier of the gene for it. Sickle cell ...

Some people who have long lived with the disease say they worry about living as a healthy person, while others are concerned about the obstacles to getting treatment. By Gina Kolata Gina Kolata has ...

Sickle cell disease (SCD) is a group of conditions that cause red blood cells to malfunction. Sickle cell anemia is a type of SCD. Healthy red blood cells are disc-shaped and flexible, which helps ...

Several herbs and plants, such as aloe vera and lemongrass, may help alleviate symptoms of sickle cell anemia. However, further research is still needed to understand the exact effects. Sickle cell ...

Amy Mason had toughed it out for hours one day this past July, trying warm soaks and heating pads and deep breathing to soothe pain that felt like her bones were being sawed with a rusty blade. She ...

It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier first described a new way to edit genes, called CRISPR, in a scientific paper. The discovery is so game-changing ...

In September, 1904, a twenty-year-old Grenadian man named Walter Clement Noel disembarked in New York after an eight-day voyage from Barbados. At the time, few Black people were permitted to study at ...

Such treatments are extraordinarily promising and costly. Will the Biden administration commit to spending that could speed clinical trial results? By Gina Kolata MESA, Ariz. — Helen Obando, 18 and ...